0,907  0,004  Eye irritation, high
0,905  0,003  Skin irritative effect
0,891  0,003  Cardiovascular analeptic
0,845  0,004  GST A substrate
0,783  0,013  Caspase 9 stimulant
0,755  0,012  Teratogen
0,744  0,012  Embryotoxic
0,735  0,008  Respiratory analeptic
0,727  0,004  Ulceration
0,701  0,008  Sensitization
0,698  0,008  Analeptic
0,693  0,007  5 Hydroxytryptamine release stimulant
0,687  0,009  Cholesterol antagonist
0,686  0,011  Antihypercholesterolemic
0,675  0,005  5 Hydroxytryptamine release inhibitor
0,668  0,005  Antipruritic, allergic
0,666  0,004  Anesthetic general
0,664  0,003  FMO1 substrate
0,651  0,003  Acaricide
0,615  0,014  Vasodilator, peripheral
0,605  0,003  Antiparkinsonian, rigidity relieving
0,606  0,010  Histamine release inhibitor
0,615  0,023  TNF expression inhibitor
0,635  0,044  Antiinflammatory
0,604  0,017  Carcinogenic
0,598  0,014  Radioprotector
0,594  0,011  Lipoprotein disorders treatment
0,592  0,014  Immunosuppressant
0,586  0,009  Cardiodepressant
0,590  0,017  Antithrombotic
0,589  0,020  Aldehyde oxidase inhibitor
0,562  0,005  Antiseptic
0,564  0,010  Antipyretic
0,555  0,009  Hypolipemic
0,563  0,019  Antiallergic
0,547  0,003  Succinate dehydrogenase inhibitor
0,554  0,014  GABA C receptor rho-3 antagonist
0,550  0,017  Mutagenic
0,536  0,010  Platelet antagonist
0,531  0,009  Psychostimulant
0,527  0,006  Anesthetic
0,519  0,004  Aldehyde dehydrogenase inhibitor
0,533  0,019  CTGF expression inhibitor
0,513  0,009  Antihypoxic
0,522  0,020  Spasmolytic
0,512  0,013  Antiglaucomic
0,498  0,005  Skeletal muscle relaxant
0,551  0,060  Apoptosis agonist
0,493  0,003  Antipruritic, non-allergic
0,496  0,010  Platelet aggregation inhibitor
0,493  0,008  Muscle relaxant
0,498  0,018  Antihypertensive
0,484  0,009  Radiosensitizer
0,485  0,013  Vasodilator
0,470  0,004  Antiparkinsonian, tremor relieving
0,469  0,006  Alpha-N-acetylglucosaminidase inhibitor
0,487  0,029  CYP2C19 substrate
0,482  0,026  Immunomodulator
0,463  0,009  Carcinogenic, group 3
0,471  0,020  Vasodilator, coronary
0,462  0,015  Antihypertriglyceridemic
0,471  0,024  Apoptosis antagonist
0,453  0,009  Hair growth stimulant
0,455  0,012  Antiulcerative
0,444  0,006  GST P1-1 substrate
0,455  0,017  Antidiabetic symptomatic
0,437  0,003  Photosensitizer
0,442  0,009  Diabetic retinopathy treatment
0,460  0,028  Cardioprotectant
0,441  0,010  Non-steroidal antiinflammatory agent
0,431  0,004  Antihyperlipoproteinemic
0,442  0,025  ICAM1 expression inhibitor
0,422  0,007  Protein kinase stimulant
0,447  0,033  Antifungal
0,451  0,037  Immunostimulant
0,423  0,013  FMO3 substrate
0,419  0,009  Phospholipase C inhibitor
0,420  0,014  Flavin-containing monooxygenase substrate
0,435  0,031  Antiischemic
0,430  0,029  Cytostatic
0,451  0,053  Transcription factor NF kappa B inhibitor
0,402  0,005  Gastrin inhibitor
0,420  0,024  DNA damaging
0,410  0,015  Abortion inducer
0,405  0,011  GST M1-1 substrate
0,396  0,007  Anesthetic local
0,401  0,014  5 Hydroxytryptamine uptake stimulant
0,391  0,005  Phospholipase A2 inhibitor
0,412  0,028  UGT2B4 substrate
0,391  0,009  Tyrosine 3 hydroxylase inhibitor
0,392  0,012  Platelet adhesion inhibitor
0,384  0,005  Antihelmintic (Nematodes)
0,399  0,021  Peroxidase inhibitor
0,398  0,022  DNA synthesis inhibitor
0,381  0,007  Glutathione S-transferase substrate
0,391  0,017  P-glycoprotein inhibitor
0,377  0,004  Cyclooxygenase 3 inhibitor
0,398  0,027  Superoxide dismutase inhibitor
0,375  0,009  Antidote
0,368  0,005  Interleukin 4 antagonist
0,383  0,021  Sedative
0,365  0,002  GST T1-1 substrate
0,386  0,024  Vascular (periferal) disease treatment
0,372  0,012  VCAM1 expression inhibitor
0,370  0,011  Lipocortins synthesis antagonist
0,388  0,029  Calcium channel activator
0,394  0,036  UGT1A9 substrate
0,360  0,004  Alcohol oxidase inhibitor
0,361  0,005  Mediator release inhibitor
0,391  0,036  Chemoprotective
0,357  0,005  Antineoplastic, alkylator
0,378  0,027  Myocardial infarction treatment
0,371  0,021  Cyclic AMP phosphodiesterase inhibitor
0,377  0,028  Antiparasitic
0,384  0,035  NOS2 expression inhibitor
0,380  0,034  Antiprotozoal (Leishmania)
0,363  0,019  Antimutagenic
0,373  0,033  Hypoglycemic
0,365  0,025  Interleukin agonist
0,402  0,062  CYP2C9 substrate
0,365  0,027  Antineoplastic (endocrine cancer)
0,341  0,005  Adenylate kinase inhibitor
0,348  0,012  Muscular dystrophy treatment
0,379  0,048  Antipsoriatic
0,340  0,012  Sepsis treatment
0,351  0,024  RNA-directed DNA polymerase inhibitor
0,330  0,005  Alcohol dehydrogenase substrate
0,361  0,036  Proliferative diseases treatment
0,392  0,068  Atherosclerosis treatment
0,369  0,047  NOS3 expression inhibitor
0,384  0,062  Stroke treatment
0,323  0,004  Toll-Like receptor 2 antagonist
0,384  0,067  CYP3A4 substrate
0,330  0,013  Antineoplastic antimetabolite
0,349  0,033  UGT1A6 substrate
0,325  0,012  CNS active muscle relaxant
0,309  0,005  Catalase inhibitor
0,338  0,036  Angiogenesis stimulant
0,314  0,012  Pancreatic disorders treatment
0,327  0,026  Antihelmintic
0,311  0,012  Alkylator
0,349  0,051  Lipoxygenase inhibitor
0,302  0,006  Antispirochetal
0,358  0,063  Bone diseases treatment
0,381  0,086  Antibacterial
0,317  0,023  UGT2B7 substrate
0,295  0,003  Ornithine decarboxylase inhibitor
0,304  0,015  Insulin sensitizer
0,359  0,070  Thyroid hormone antagonist
0,298  0,010  Carcinogenic, group 1
0,332  0,046  Cytotoxic
0,386  0,100  Antiarthritic
0,289  0,004  Acetylcholine release stimulant
0,364  0,080  Calpain 2 inhibitor
0,290  0,007  Antieczematic
0,291  0,009  Antiviral (Poxvirus)
0,299  0,022  Antiacne
0,328  0,053  Antioxidant
0,276  0,003  Arachidonic acid antagonist
0,275  0,004  Interferon agonist
0,279  0,009  Antibacterial (Helicobacter pylori)
0,281  0,012  Antifungal enhancer
0,293  0,025  Pneumotoxic
0,272  0,005  Coagulant
0,296  0,031  Myocardial ischemia treatment
0,274  0,010  Ferrochelatase inhibitor
0,334  0,074  Thyroid hormone beta antagonist
0,280  0,024  Restenosis treatment
0,260  0,005  Antirickettsial
0,275  0,022  Lipid peroxidase inhibitor
0,276  0,024  Interferon gamma antagonist
0,321  0,070  AR expression inhibitor
0,254  0,003  Antidote, heavy metal
0,255  0,005  TRPA1 agonist
0,281  0,032  Antianginal
0,259  0,010  Farnesoid X receptor antagonist
0,258  0,011  Neurotrophic factor
0,259  0,013  UDP-glucose 4-epimerase inhibitor
0,272  0,027  Neurotrophic factor enhancer
0,265  0,022  Bone formation stimulant
0,254  0,012  UGT2B10 substrate
0,309  0,067  Interleukin 2 agonist
0,282  0,040  Septic shock treatment
0,247  0,007  Aldehyde dehydrogenase substrate
0,272  0,033  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,247  0,009  Calcium antagonist
0,243  0,005  Actinic keratosis treatment
0,301  0,066  Antiosteoporotic
0,242  0,007  Triose-phosphate isomerase inhibitor
0,242  0,009  Carbonic anhydrase XIII inhibitor
0,271  0,038  Hepatoprotectant
0,233  0,002  Antiviral (Parainfluenza)
0,250  0,020  Aldehyde oxidase substrate
0,260  0,032  CYP2B6 inhibitor
0,258  0,032  Thrombolytic
0,231  0,005  Sphingosine 1-phosphate receptor 4 antagonist
0,272  0,047  Chemopreventive
0,264  0,040  Growth hormone agonist
0,254  0,031  Antiviral (Herpes)
0,248  0,025  Antipruritic
0,247  0,024  Monophenol monooxygenase inhibitor
0,239  0,018  Cell wall synthesis inhibitor
0,235  0,015  Shock treatment
0,226  0,006  Adenylate cyclase stimulant
0,232  0,013  Antiprotozoal (Trichomonas)
0,238  0,019  Toll-Like receptor antagonist
0,227  0,009  Phosphofructokinase-1 inhibitor
0,218  0,002  Ca2+-transporting ATPase inhibitor
0,223  0,008  Vanilloid 1 agonist
0,221  0,006  Electrolyte absorption antagonist
0,244  0,030  Amylase inhibitor
0,235  0,021  VEGF expression inhibitor
0,218  0,005  Sphingosine 1-phosphate receptor 2 antagonist
0,216  0,003  Lysophosphatidic acid 2 receptor antagonist
0,216  0,004  Paget's disease treatment
0,232  0,021  Antiviral (Ebola)
0,217  0,006  Sphingosine 1-phosphate receptor 5 antagonist
0,227  0,016  Carcinogenic, group 2B
0,214  0,004  Acyl-CoA dehydrogenase inhibitor
0,216  0,007  Sphingomyelinase inhibitor
0,224  0,016  GABA C receptor agonist
0,216  0,009  Gastric antisecretory
0,216  0,010  GABA C receptor antagonist
0,217  0,011  Carbonic anhydrase VI inhibitor
0,221  0,015  Raynaud's phenomenon treatment
0,266  0,062  Free radical scavenger
0,250  0,047  UGT1A1 substrate
0,231  0,028  Acute respiratory distress syndrome (ARDS) treatment
0,224  0,022  ATPase inhibitor
0,270  0,070  Cardiotonic
0,220  0,020  GABA C receptor rho-2 antagonist
0,205  0,004  Restless leg syndrome treatment
0,312  0,113  Antineoplastic (breast cancer)
0,202  0,003  Interferon inducer
0,216  0,018  Aminopeptidase B inhibitor
0,247  0,050  Wound healing agent
0,242  0,045  Antiviral (West Nile virus)
0,227  0,032  Acetylcholine M1 receptor antagonist
0,199  0,004  Elastase 1 inhibitor
0,246  0,053  Nitric oxide antagonist
0,198  0,004  Acetyl-CoA transferase inhibitor
0,226  0,033  Melanin inhibitor
0,197  0,005  Glutathione S-transferase inhibitor
0,200  0,008  Thioredoxin inhibitor
0,206  0,015  Carbonic anhydrase III inhibitor
0,214  0,024  Cholesterol synthesis inhibitor
0,218  0,027  Uterine stimulant
0,270  0,079  Insulysin inhibitor
0,217  0,028  Neurotensin receptor agonist
0,251  0,064  Calpain inhibitor
0,218  0,031  UGT2B9 substrate
0,244  0,059  Antihypotensive
0,281  0,097  Sodium/bile acid cotransporter inhibitor
0,222  0,038  Cytidine deaminase inhibitor
0,188  0,004  Glycine receptor agonist
0,184  0,003  Anesthetic inhalation
0,307  0,127  15-Lipoxygenase inhibitor
0,188  0,008  Toll-Like receptor 4 antagonist
0,204  0,025  Adenylate cyclase inhibitor
0,199  0,020  Microtubule formation inhibitor
0,189  0,011  Prolactin inhibitor
0,190  0,012  Antiviral (Influenza B)
0,212  0,035  Toxic, respiratory center
0,194  0,018  Growth stimulant
0,203  0,027  DNA polymerase I inhibitor
0,227  0,051  Nitric-oxide synthase stimulant
0,301  0,125  CYP2C19 inhibitor
0,185  0,010  Keratolytic
0,183  0,008  Toll-Like receptor 2 agonist
0,196  0,022  Excitatory amino acid transporter EAAC1 inhibitor
0,183  0,011  GABA C receptor rho-1 antagonist
0,194  0,023  Retinoprotector
0,221  0,050  UGT1A4 substrate
0,182  0,011  Antiviral (Papilloma)
0,185  0,015  HDL-cholesterol increasing
0,190  0,020  Bronchodilator
0,251  0,082  Transcription factor STAT3 inhibitor
0,233  0,064  Anticonvulsant
0,336  0,167  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,175  0,007  Antiprotozoal activity enhancer
0,224  0,058  DNA methyltransferase I inhibitor
0,227  0,062  Antialcoholic
0,242  0,077  Antineoplastic (liver cancer)
0,170  0,005  Sphingosine 1-phosphate receptor 4 agonist
0,186  0,022  SULT1A1 substrate
0,211  0,047  Antianorexic
0,200  0,036  Phobic disorders treatment
0,199  0,036  Genotoxic
0,167  0,004  Endocannabinoid uptake inhibitor
0,262  0,102  Caspase 3 stimulant
0,169  0,010  Anabolic
0,178  0,019  Mucolytic
0,174  0,016  Creatine kinase inhibitor
0,259  0,101  CYP2D6 substrate
0,281  0,123  Toll-Like receptor agonist
0,164  0,006  Antiviral (Herpesvirus 3, Human)
0,165  0,008  Interleukin 5 antagonist
0,166  0,011  Antifungal (Pneumocystis)
0,157  0,003  Lysophosphatidic acid 3 receptor antagonist
0,158  0,004  Potassium channel Kv1.3 blocker
0,202  0,050  UGT1A3 substrate
0,169  0,018  Caspase 3 inhibitor
0,159  0,009  Ornithine carbamoyltransferase inhibitor
0,160  0,010  Antiviral (Rhinovirus)
0,183  0,033  CF transmembrane conductance regulator agonist
0,158  0,010  Carbamoyl phosphate synthetase inhibitor
0,179  0,031  Cell adhesion inhibitor
0,170  0,022  Contraceptive female
0,158  0,012  Glutamate decarboxylase inhibitor
0,156  0,010  Lanosterol 14 alpha demethylase inhibitor
0,159  0,013  Macrophage migration inhibitory factor inhibitor
0,159  0,014  Glutamate dehydrogenase inhibitor
0,229  0,086  Tumour necrosis factor alpha release inhibitor
0,174  0,030  5-Lipoxygenase inhibitor
0,235  0,092  Antiprotozoal (Trypanosoma)
0,187  0,044  Corneal wound healing stimulator
0,149  0,006  Anticholelithogenic
0,153  0,010  Dyspepsia treatment
0,153  0,010  Vanilloid agonist
0,165  0,023  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,315  0,173  Antineoplastic (solid tumors)
0,180  0,038  Cocaine dependence treatment
0,151  0,011  Argininosuccinate synthase inhibitor
0,180  0,042  Nav1.2 sodium channel blocker
0,174  0,036  Movement disorders treatment
0,167  0,029  Expectorant
0,151  0,014  UGT2B11 substrate
0,141  0,004  Gaucher disease treatment
0,140  0,004  Exportin-1 inhibitor
0,152  0,016  Interleukin 1 beta converting enzyme inhibitor
0,169  0,034  Antihemorrhagic
0,197  0,062  Antiviral (Hepatitis)
0,208  0,074  DNA methylase inhibitor
0,153  0,019  Electron transport complex I inhibitor
0,212  0,078  Interleukin antagonist
0,138  0,004  Purinergic P2Y12 antagonist
0,186  0,053  Antineoplastic (bone cancer)
0,146  0,013  CDC25A inhibitor
0,161  0,028  Choleretic
0,158  0,026  UGT2B1 substrate
0,141  0,010  Carbonic anhydrase VB inhibitor
0,137  0,006  Acetylcholine M5 receptor agonist
0,157  0,028  Antiviral (CMV)
0,164  0,035  Antiprotozoal (Amoeba)
0,144  0,016  Antidote, mercury
0,133  0,006  Estrogen-related receptor beta agonist
0,142  0,015  Peroxisome proliferator-activated receptor gamma agonist
0,132  0,004  Glutamate (mGluR6) antagonist
0,139  0,012  Leukotriene antagonist
0,166  0,039  Nav1.3 sodium channel blocker
0,164  0,037  Cathepsin H inhibitor
0,164  0,039  Proteasome inhibitor
0,152  0,027  Antineoplastic alkaloid
0,176  0,050  Thiol protease inhibitor
0,179  0,054  Antiviral (Influenza A)
0,164  0,040  Nav1.6 sodium channel blocker
0,169  0,045  Calcium channel blocker
0,177  0,053  Antiischemic, cerebral
0,216  0,093  Heart failure treatment
0,161  0,038  Acetylcholine muscarinic antagonist
0,127  0,004  Acetyl-CoA transferase 2 inhibitor
0,171  0,048  Antiprotozoal (Coccidial)
0,235  0,112  CYP1A2 substrate
0,170  0,048  SULT1A3 substrate
0,161  0,039  Antihelmintic (Trematoda)
0,126  0,004  Nitric oxide donor
0,127  0,005  Squalene synthetase inhibitor
0,131  0,010  Antiemphysemic
0,167  0,046  Skin whitener
0,292  0,170  Antidiabetic
0,292  0,170  Cyclophilin D inhibitor
0,179  0,058  Prostate disorders treatment
0,161  0,040  Antiviral (Hepatitis B)
0,124  0,003  Glucose-6-phosphate isomerase inhibitor
0,127  0,006  Purinergic P2Y antagonist
0,127  0,007  Leukocyte elastase inhibitor
0,230  0,111  Antiepileptic
0,193  0,075  5 Hydroxytryptamine 3E antagonist
0,141  0,023  Acetylcholine nicotinic antagonist
0,164  0,045  Cholinergic antagonist
0,129  0,011  Granulocyte macrophage colony stimulating factor agonist
0,195  0,078  Antiviral (Influenza)
0,138  0,021  ABCA1 expression enhancer
0,245  0,128  Antineoplastic (lung cancer)
0,131  0,016  Glutamate release inhibitor
0,223  0,108  Transcription factor STAT inhibitor
0,127  0,013  Narcolepsy treatment
0,138  0,025  Alcohol dehydrogenase inhibitor
0,118  0,005  Sphingosine kinase inhibitor
0,113  0,001  Lysophosphatidic acid receptor 3 agonist
0,172  0,060  Neuropathy treatment
0,145  0,033  Anticataract
0,123  0,012  Antiviral (Hepatitis A)
0,164  0,053  Hemostatic
0,134  0,024  Cathepsin G inhibitor
0,118  0,008  GABA B receptor agonist
0,125  0,016  Acetylcholine M4 receptor antagonist
0,128  0,019  Phosphodiesterase 6D inhibitor
0,160  0,053  Renal failure treatment
0,118  0,011  CDC25B inhibitor
0,154  0,048  Acetylcholine antagonist
0,141  0,034  Antihelmintic (Fasciola)
0,130  0,024  NADH dehydrogenase inhibitor
0,123  0,017  Glycine receptor antagonist
0,120  0,014  Antimetabolite
0,146  0,040  Menstruation disorders treatment
0,121  0,016  Leukotriene synthesis inhibitor
0,105  0,002  Lysophosphatidic acid receptor 1 agonist
0,121  0,018  Lipase inhibitor
0,108  0,005  Alpha-mannosidase inhibitor
0,108  0,006  Sphingosine 1-phosphate receptor 3 antagonist
0,118  0,016  Amidase inhibitor
0,206  0,106  Antineoplastic (renal cancer)
0,121  0,021  Carbonic anhydrase V inhibitor
0,126  0,026  Porphobilinogen synthase inhibitor
0,109  0,010  Antimycoplasmal
0,118  0,021  Bile acid receptor antagonist
0,165  0,068  Cystic fibrosis treatment
0,105  0,008  Aconitate hydratase inhibitor
0,160  0,063  Pulmonary hypertension treatment
0,119  0,023  Antileprosy
0,115  0,019  Na+ K+ transporting ATPase inhibitor
0,165  0,070  Antiviral (Hepatitis C)
0,115  0,019  Carbonic anhydrase VA inhibitor
0,198  0,102  Antineoplastic (cervical cancer)
0,156  0,061  Antineoplastic (squamous cell carcinoma)
0,103  0,008  Potassium channel intermediate-conductance Ca-activated blocker
0,104  0,010  Carbonic anhydrase XIV inhibitor
0,104  0,012  Antidote, organophosphates
0,121  0,029  Toll-Like receptor 3 antagonist
0,146  0,054  Heat shock protein 70 antagonist
0,093  0,001  Carbonic anhydrase X inhibitor
0,093  0,001  Carbonic anhydrase VIII inhibitor
0,118  0,026  Transcription factor NF kappa B stimulant
0,100  0,009  Oleamide hydrolase inhibitor
0,155  0,063  Hearing loss treatment
0,138  0,047  Cystathionine beta-synthase inhibitor
0,096  0,005  Cholesterol esterase inhibitor
0,179  0,089  Amyloid beta aggregation inhibitor
0,096  0,006  Lipocortins synthesis agonist
0,110  0,020  Calcium channel L-type blocker
0,094  0,005  Acetyl-CoA transferase 1 inhibitor
0,159  0,070  Protein-tyrosine phosphatase inhibitor
0,094  0,005  Prostaglandin agonist
0,109  0,020  Antiviral (Dengue virus)
0,122  0,033  Acetylcholine M3 receptor agonist
0,098  0,010  Elastase inhibitor
0,130  0,043  Xanthine oxidase inhibitor
0,098  0,011  Leukotriene B4 antagonist
0,128  0,041  Myasthenia Gravis treatment
0,105  0,019  Sphingosine 1-phosphate receptor antagonist
0,103  0,018  Biliverdin reductase inhibitor
0,103  0,018  Prostaglandin EP2 antagonist
0,091  0,007  Squalene epoxidase inhibitor
0,106  0,022  Epoxide hydrolase inhibitor
0,190  0,106  Antiamyloidogenic
0,093  0,010  Glucosylceramidase inhibitor
0,173  0,090  UDP-glucuronosyltransferase substrate
0,088  0,005  Leukotriene C antagonist
0,090  0,007  Mannosidase inhibitor
0,087  0,004  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,104  0,021  Narcotic antagonist
0,092  0,010  Sphingosine kinase 2 inhibitor
0,098  0,016  Protease 3C (Human rhinovirus) inhibitor
0,110  0,029  Cell adhesion molecule inhibitor
0,123  0,043  Sulfotransferase substrate
0,098  0,017  Beta adrenoreceptor antagonist
0,122  0,042  Chronic obstructive bronchitis treatment
0,109  0,029  ATPase (Vacuolar H+) inhibitor
0,084  0,005  Benzodiazepine antagonist
0,104  0,026  Aminopeptidase I inhibitor
0,153  0,075  Diuretic
0,092  0,014  Peroxisome proliferator-activated receptor alpha agonist
0,186  0,108  Age-related macular degeneration treatment
0,132  0,054  Protein-tyrosine phosphatase 1B inhibitor
0,083  0,005  Acetylcholine M4 receptor agonist
0,115  0,038  Tourette's syndrome treatment
0,111  0,034  Antifungal (Candida)
0,128  0,052  Interleukin 8 antagonist
0,081  0,005  Membrane dipeptidase inhibitor
0,121  0,045  Carbonic anhydrase XV inhibitor
0,107  0,032  Tocolytic
0,122  0,047  Neutropenia treatment
0,102  0,027  Selectin antagonist
0,080  0,005  Sphingosine kinase 1 inhibitor
0,090  0,015  Thromboxane antagonist
0,212  0,138  12-Lipoxygenase inhibitor
0,201  0,127  Antineoplastic (pancreatic cancer)
0,076  0,003  Prostaglandin F2 alpha agonist
0,130  0,057  Beta amyloid protein antagonist
0,131  0,057  Antitussive
0,080  0,007  Pregnane X receptor antagonist
0,160  0,088  Dual specificity phosphatase 3 inhibitor
0,081  0,009  Adenosine deaminase inhibitor
0,074  0,003  Elastase 3B inhibitor
0,074  0,003  Elastase 3A inhibitor
0,074  0,003  Elastase 2B inhibitor
0,094  0,022  Vanilloid 4 agonist
0,119  0,047  Antiprotozoal (Toxoplasma)
0,160  0,089  Tumour necrosis factor antagonist
0,081  0,011  Thromboxane synthase inhibitor
0,123  0,054  GABA receptor agonist
0,074  0,006  Cytokine production stimulant
0,077  0,009  Adenylate cyclase 1 inhibitor
0,082  0,014  Thromboxane A2 antagonist
0,087  0,020  Acetylcholine muscarinic agonist
0,077  0,010  Vanilloid 2 antagonist
0,187  0,120  Acute neurologic disorders treatment
0,087  0,021  Neuraminidase (influenza) inhibitor
0,120  0,054  Falcipain 3 inhibitor
0,075  0,009  Glutamate (mGluR1a) antagonist
0,098  0,033  Histidine decarboxylase inhibitor
0,075  0,009  Retinoid X receptor agonist
0,089  0,023  Phospholipase D inhibitor
0,072  0,007  Purinergic P2T antagonist
0,079  0,014  Postcoital contraceptive
0,100  0,035  Histamine H2 receptor antagonist
0,119  0,054  Chelator
0,115  0,051  DOPA decarboxylase inhibitor
0,078  0,014  Sphingosine 1-phosphate receptor 1 antagonist
0,096  0,033  Thioredoxin reductase inhibitor
0,114  0,051  Antischistosomal
0,084  0,023  Neuraminidase inhibitor
0,195  0,134  Amyotrophic lateral sclerosis treatment
0,087  0,025  Peroxisome proliferator-activated receptor gamma antagonist
0,086  0,025  NMDA receptor glycine site agonist
0,068  0,008  Arginase inhibitor
0,083  0,023  Uterine relaxant
0,065  0,005  Sodium-dependent vitamin C transporter 2 inhibitor
0,064  0,004  Elastase 2A inhibitor
0,064  0,004  Elastase 2 inhibitor
0,123  0,063  Autism spectrum disorders treatment
0,130  0,071  NADPH oxidase inhibitor
0,190  0,131  Antineoplastic (ovarian cancer)
0,103  0,044  Carcinogenic, group 2A
0,106  0,047  Posttraumatic stress disorder treatment
0,096  0,038  mTOR complex 2 inhibitor
0,063  0,005  Leukotriene C4 antagonist
0,066  0,008  GABA uptake inhibitor
0,137  0,080  Pregnane X receptor agonist
0,061  0,003  Calcium-independent phospholipase A2 inhibitor
0,079  0,021  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,158  0,100  LDLR expression enhancer
0,084  0,027  NMDA receptor agonist
0,093  0,036  Caspase 7 inhibitor
0,088  0,031  Phosphodiesterase VI inhibitor
0,061  0,005  Angiotensin AT1 receptor antagonist
0,083  0,028  Potassium channel (Tandem pore domain) blocker
0,122  0,068  DNA repair enzyme inhibitor
0,086  0,031  Phosphodiesterase III inhibitor
0,095  0,040  NAD(P)H dehydrogenase (quinone) inhibitor
0,078  0,025  Androgen agonist
0,080  0,027  Glutamate (mGluR7) antagonist
0,063  0,010  Nicotinic acid receptor agonist
0,079  0,027  SULT2A1 substrate
0,134  0,082  UGT2B15 substrate
0,056  0,005  Angiotensin II receptor antagonist
0,061  0,010  Antiviral (Enterovirus)
0,058  0,008  Kainate receptor agonist
0,058  0,007  Retinoid X receptor antagonist
0,055  0,005  Leukotriene B4 receptor 1 antagonist
0,130  0,080  Cytokine production inhibitor
0,065  0,015  5-Alpha-reductase inhibitor
0,073  0,024  Beta 1 adrenoreceptor antagonist
0,058  0,009  Glutamate (mGluR3) antagonist
0,202  0,153  Hepatic disorders treatment
0,078  0,030  Acetylcholine M2 receptor antagonist
0,069  0,021  Beta 2 adrenoreceptor agonist
0,061  0,013  Geranyltranstransferase inhibitor
0,052  0,005  Prostaglandin EP2 agonist
0,127  0,079  Interleukin 1 antagonist
0,059  0,011  Retinoid X alpha receptor agonist
0,075  0,029  Ribonucleotide reductase inhibitor
0,073  0,027  Ribonucleoside-diphosphate reductase inhibitor
0,055  0,009  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,066  0,020  Acetylcholine M1 receptor agonist
0,052  0,007  Uridine phosphorylase inhibitor
0,049  0,004  DNA polymerase III inhibitor
0,065  0,020  Beta 2 adrenoreceptor antagonist
0,052  0,007  Vanilloid 3 antagonist
0,053  0,009  Angiotensin AT2 receptor antagonist
0,048  0,005  Glutamate (mGluR3) agonist
0,084  0,041  NAT1 substrate
0,050  0,007  Retinoid X alpha receptor antagonist
0,050  0,007  Ceramide glucosyltransferase inhibitor
0,080  0,037  S-adenosyl-L-methionine decarboxylase inhibitor
0,076  0,034  Hyperparathyroidism treatment
0,054  0,012  Fumarate hydratase inhibitor
0,045  0,003  Calcium-dependent phospholipase A2 inhibitor
0,055  0,014  Dihydropteroate synthase inhibitor
0,045  0,004  Glucosylceramidase stimulant
0,056  0,015  Guanylate cyclase inhibitor
0,043  0,003  Isoleucine-tRNA ligase inhibitor
0,051  0,011  Delayed rectifier potassium channel blocker
0,062  0,022  Prolyl endopeptidase inhibitor
0,058  0,019  Fructose-1,6-bisphosphatase inhibitor
0,083  0,044  Antibiotic
0,047  0,008  Benzodiazepine receptor peripheral-type antagonist
0,044  0,005  Glutamate (mGluR1) agonist
0,084  0,046  Nicotinic alpha4beta2 receptor antagonist
0,061  0,022  Heparanase inhibitor
0,047  0,009  Prostaglandin D2 agonist
0,042  0,004  Vanilloid 2 agonist
0,055  0,017  Neuraminidase (Influenza A) inhibitor
0,053  0,015  Dihydrofolate reductase inhibitor
0,106  0,068  Protein kinase C gamma inhibitor
0,185  0,148  Neuropeptide Y2 antagonist
0,077  0,040  Phenylalanine 4-hydroxylase inhibitor
0,141  0,105  Dual specificity phosphatase inhibitor
0,041  0,004  Acid ceramidase inhibitor
0,064  0,028  Ryanodine receptor antagonist
0,217  0,181  Toll-Like receptor 7 agonist
0,053  0,017  Sphingosine 1-phosphate receptor 1 agonist
0,054  0,018  Histamine H2 receptor agonist
0,039  0,005  Hedgehog signaling activator
0,052  0,018  Thymidine kinase inhibitor
0,045  0,010  Hypoxanthine phosphoribosyltransferase inhibitor
0,067  0,034  Carbonic anhydrase stimulant
0,086  0,053  Inducible nitric-oxide synthase inhibitor
0,224  0,191  Antiprotozoal
0,117  0,084  Gastritis treatment
0,192  0,159  Antimycobacterial
0,192  0,160  Antineoplastic (multiple myeloma)
0,050  0,018  Dopamine D5 agonist
0,054  0,022  Microtubule stabilization
0,068  0,036  Beta 3 adrenoreceptor antagonist
0,054  0,022  Sphingosine 1-phosphate receptor agonist
0,059  0,027  Nicotinic alpha3beta2 receptor antagonist
0,097  0,066  Nitric-oxide synthase inhibitor
0,036  0,005  Lysophosphatidic acid 1 receptor antagonist
0,101  0,070  Antiinfertility, female
0,045  0,014  Peroxisome proliferator-activated receptor delta agonist
0,050  0,020  Leukotriene A4 hydrolase inhibitor
0,088  0,057  Acetylcholine agonist
0,033  0,003  Carbonic anhydrase XI inhibitor
0,066  0,036  Purinergic P2X1 antagonist
0,045  0,016  Cholesterol absorption inhibitor
0,095  0,066  Butyrylcholinesterase inhibitor
0,043  0,014  Free fatty acid receptor 1 antagonist
0,045  0,016  Glutamate (mGluR8) agonist
0,036  0,007  Nicotinic acid receptor 2 antagonist
0,055  0,027  Bombesin 2 receptor antagonist
0,123  0,095  Cyclooxygenase inhibitor
0,083  0,056  Antiviral (RSV)
0,057  0,030  Sphingosine 1-phosphate receptor 5 agonist
0,113  0,085  Acetylcholinesterase inhibitor
0,051  0,024  Phosphodiesterase 3B inhibitor
0,036  0,008  Prostaglandin E2 agonist
0,032  0,005  Prostacyclin agonist
0,049  0,022  Glutamate (mGluR group III) antagonist
0,050  0,024  Dihydroorotase inhibitor
0,039  0,013  Methionyl aminopeptidase 1 inhibitor
0,048  0,023  Glutamate (mGluR4) antagonist
0,033  0,008  Toll-Like receptor 4 agonist
0,035  0,010  Purinergic P2Y15 antagonist
0,229  0,205  DNA directed DNA polymerase inhibitor
0,032  0,008  Glutamate (mGluR1a) agonist
0,182  0,159  Prostate cancer treatment
0,062  0,039  Acetylcholine M5 receptor antagonist
0,028  0,005  Neuraminidase (Influenza B) inhibitor
0,028  0,005  Toll-Like receptor 8 agonist
0,084  0,062  Histamine N-methyltransferase inhibitor
0,144  0,122  Antiarrhythmic
0,038  0,016  Melatonin receptor 1A agonist
0,040  0,019  Phosphoglycerate kinase inhibitor
0,027  0,005  Retinoid X beta receptor antagonist
0,079  0,058  Adrenaline agonist
0,058  0,038  Fatty acid synthase inhibitor
0,062  0,041  Cannabinoid CB1 receptor agonist
0,024  0,005  Vitamin D receptor agonist
0,024  0,004  Thromboxane A2 agonist
0,025  0,006  Ileal bile acid transport inhibitor
0,031  0,012  Thyroid hormone agonist
0,031  0,013  1,3-Beta-glucan synthase inhibitor
0,059  0,041  Heat shock protein 90 beta antagonist
0,036  0,018  GABA transporter 3 inhibitor
0,046  0,028  Beta adrenoreceptor agonist
0,073  0,056  GABA aminotransferase inhibitor
0,043  0,025  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,036  0,019  Adenosine uptake inhibitor
0,026  0,009  Corticosteroid-like
0,031  0,015  Leukotriene D4 antagonist
0,036  0,020  Carnitine palmitoyltransferase inhibitor
0,031  0,014  Estrogen-related receptor gamma antagonist
0,020  0,004  DNA polymerase III polC-type inhibitor
0,066  0,050  MDM2 inhibitor
0,022  0,006  Purinergic P2Y1 agonist
0,019  0,003  Angiotensin AT2 receptor agonist
0,021  0,005  Angiotensin AT1B receptor antagonist
0,133  0,118  Interleukin 6 antagonist
0,098  0,083  Antihypermotility
0,026  0,011  Fructose-1,6-bisphosphatase 1 inhibitor
0,051  0,036  Cannabinoid CB2 receptor antagonist
0,043  0,029  GABA B receptor antagonist
0,109  0,094  Contraceptive
0,036  0,022  Calcitonin receptor agonist
0,035  0,020  Carboxypeptidase B inhibitor
0,027  0,012  Retinoic acid receptor agonist
0,075  0,061  Chymotrypsin inhibitor
0,053  0,040  Maillard reaction inhibitor
0,025  0,012  Leukotriene B4 receptor 2 antagonist
0,167  0,154  Antineoplastic (melanoma)
0,057  0,043  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,058  0,045  Phosphodiesterase 1A inhibitor
0,054  0,041  Adenine nucleotide translocase inhibitor
0,051  0,038  Autotaxin inhibitor
0,067  0,054  Protein kinase C beta inhibitor
0,053  0,041  Angiotensin-converting enzyme inhibitor
0,020  0,009  Methylmalonyl-CoA mutase inhibitor
0,042  0,031  Heme oxygenase inhibitor
0,042  0,030  Oxytocin agonist
0,022  0,011  Retinoic acid beta receptor agonist
0,019  0,009  Telomerase stimulant
0,015  0,005  Thromboxane agonist
0,013  0,003  DNA polymerase III subunit alpha inhibitor
0,048  0,039  Diacylglycerol O-acyltransferase inhibitor
0,019  0,009  Prostaglandin EP4 agonist
0,032  0,022  ATP citrate lysase inhibitor
0,020  0,010  Estrogen-related receptor gamma agonist
0,020  0,011  Apical sodium codependent bile acid transporter inhibitor
0,020  0,011  Antibiotic Anthracycline-like
0,056  0,047  Acetylcholine M3 receptor antagonist
0,021  0,012  Caspase 8 inhibitor
0,047  0,038  Dopamine beta hydroxylase inhibitor
0,104  0,096  Transcription factor STAT6 inhibitor
0,017  0,009  Thyroid hormone alpha antagonist
0,025  0,018  Prostaglandin H2 antagonist
0,022  0,015  Angiotensin AT1A receptor antagonist
0,022  0,015  Peroxisome proliferator-activated receptor alpha antagonist
0,018  0,011  G-protein-coupled receptor 120 agonist
0,048  0,041  5 Hydroxytryptamine 4 antagonist
0,043  0,036  Carbonic anhydrase VII inhibitor
0,045  0,039  Metalloproteinase-3 inhibitor
0,043  0,036  Glycine transporter 2 inhibitor
0,032  0,026  Carnitine palmitoyltransferase 1 inhibitor
0,046  0,040  HCV NS3/NS4A protease inhibitor
0,033  0,027  Kainate receptor 2 antagonist
0,090  0,085  AMP-activated protein kinase stimulant
0,033  0,027  HMG CoA reductase inhibitor
0,024  0,018  Sodium/glucose cotransporter 1 inhibitor
0,055  0,050  Carbonic anhydrase inhibitor
0,026  0,021  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,181  0,177  Hypoxia-inducible factor 1 alpha inhibitor
0,057  0,052  Prostaglandin F2 alpha antagonist
0,013  0,009  1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor
0,029  0,025  Epoxide hydrolase 1 inhibitor
0,070  0,066  Estrogen receptor alpha antagonist
0,011  0,008  Immunosuppressant Cyclosporine-like
0,058  0,055  Phosphodiesterase 1C inhibitor
0,038  0,036  Carbonic anhydrase IV inhibitor
0,025  0,024  LFA antagonist
0,018  0,016  5-Alpha-reductase 2 inhibitor
0,068  0,067  Antineoplastic antibiotic
0,085  0,084  Interleukin 12 antagonist
0,057  0,055  Caspase 9 inhibitor
0,043  0,042  Plasminogen activator inhibitor antagonist
0,025  0,024  Baculoviral IAP repeat-containing protein 4 inhibitor
0,115  0,115  Cholinergic
0,019  0,019  GABA transporter inhibitor
0,060  0,060  Potassium channel (ATP-sensitive) blocker
0,030  0,030  Peroxisome proliferator-activated receptor delta antagonist

